TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
1-Year Return
18.15%
This Quarter Return
+5.11%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.64B
AUM Growth
+$64M
(+2.5%)
Cap. Flow
-$37M
Cap. Flow
% of AUM
-1.4%
Top 10 Holdings %
Top 10 Hldgs %
39.72%
Holding
198
New
11
Increased
45
Reduced
37
Closed
18
Top Buys
| 1 |
UnitedHealth
UNH
|
$17.9M |
| 2 |
Stryker
SYK
|
$12.2M |
| 3 |
AstraZeneca
AZN
|
$11.8M |
| 4 |
Danaher
DHR
|
$11.6M |
| 5 |
Pfizer
PFE
|
$11.2M |
Top Sells
| 1 |
Sarepta Therapeutics
SRPT
|
$19M |
| 2 |
SHPG
Shire pic
SHPG
|
$13.4M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$13.2M |
| 4 |
Abbott
ABT
|
$10.5M |
| 5 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$8.69M |
Sector Composition
| 1 | Healthcare | 92.61% |
| 2 | Real Estate | 3% |
| 3 | Financials | 0.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
HCA Healthcare
HCA
$96.3B
| $7.7M | 0.29% |
75,090
-16,791
| -18% | -$1.72M |
|
77
Esperion Therapeutics
ESPR
$510M
| $7.42M | 0.28% |
189,287
| – | – |
|
78
Sanofi
SNY
$111B
| $7.2M | 0.27% |
179,900
| – | – |
|
79
Alkermes
ALKS
$4.77B
| $7.04M | 0.27% |
171,042
-39,140
| -19% | -$1.61M |
|
|
WMGI
80
DELISTED
Wright Medical Group Inc
WMGI
| $6.93M | 0.26% |
266,781
| – | – |
|
81
Cigna
CI
$81.2B
| $6.88M | 0.26% |
40,461
-16,102
| -28% | -$2.74M |
|
|
EPZM
82
DELISTED
Epizyme, Inc
EPZM
| $6.58M | 0.25% |
485,325
| – | – |
|
83
Novo Nordisk
NVO
$249B
| $6.27M | 0.24% |
271,800
| – | – |
|
|
DOC
84
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $6.23M | 0.24% |
391,016
+125,680
| +47% | +$2M |
|
|
SHPG
85
DELISTED
Shire pic
SHPG
| $6.11M | 0.23% |
36,216
-79,413
| -69% | -$13.4M |
|
86
ResMed
RMD
$40.1B
| $6.07M | 0.23% |
58,630
+24,811
| +73% | +$2.57M |
|
87
Ultragenyx Pharmaceutical
RARE
$3.01B
| $5.92M | 0.22% |
76,958
-71,600
| -48% | -$5.5M |
|
88
Ventas
VTR
$30.8B
| $5.61M | 0.21% |
98,496
+10,500
| +12% | +$598K |
|
89
Tenet Healthcare
THC
$17B
| $5.52M | 0.21% |
164,500
| – | – |
|
|
AVDL
90
Avadel Pharmaceuticals
AVDL
$1.46B
| $4.99M | 0.19% |
814,588
| – | – |
|
91
Editas Medicine
EDIT
$227M
| $4.94M | 0.19% |
137,801
| – | – |
|
92
Puma Biotechnology
PBYI
$257M
| $4.93M | 0.19% |
83,340
+27,355
| +49% | +$1.62M |
|
93
Masimo
MASI
$7.77B
| $4.69M | 0.18% |
48,020
+6,354
| +15% | +$620K |
|
94
United Therapeutics
UTHR
$17.2B
| $4.67M | 0.18% |
41,261
| – | – |
|
|
FOMX
95
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $4.66M | 0.18% |
930,398
| – | – |
|
96
Intellia Therapeutics
NTLA
$1.25B
| $4.58M | 0.17% |
167,381
| – | – |
|
97
Bausch Health
BHC
$2.67B
| $4.46M | 0.17% |
192,000
| – | – |
|
|
ALBO
98
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $4.44M | 0.17% |
125,000
| – | – |
|
|
ARRY
99
DELISTED
Array Biopharma Inc
ARRY
| $4.3M | 0.16% |
256,056
+100,000
| +64% | +$1.68M |
|
|
NVRO
100
DELISTED
NEVRO CORP.
NVRO
| $4.23M | 0.16% |
52,990
| – | – |
|